AVAMMUNE THERAPEUTICS

avammune-therapeutics-logo

Avammune Therapeutics is a drug discovery company focused on immuno-oncology and especially the STING pathway. Avammune is developing a multimodal approach to modulate the STING pathway to treat cancer. Their multimodal approach employs a combination of engineered viruses and small molecules.

#SimilarOrganizations #People #Financial #Website #More

AVAMMUNE THERAPEUTICS

Social Links:

Industry:
Biotechnology Therapeutics

Founded:
2017-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Website Url:
http://www.avammune.com

Total Employee:
11+

Status:
Active

Technology used in webpage:
Indian Server Location


Similar Organizations

aracari-biosciences-logo

Aracari Biosciences

Aracari is a Drug discovery company.

cero-therapeutics-logo

Cero Therapeutics

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

delix-therapeutics-logo

Delix Therapeutics

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

evariste-technologies-logo

Evariste Technologies

Biotech using quantitative modelling to make drug discovery more efficient

filament-health-logo

Filament Health

Filament Health is a natural psychedelic extraction and drug discovery company

innopharmascreen-logo

Innopharmascreen

Innopharmascreen is a ICT based drug discovery company.

kaico-logo

KAICO

KAICO is a pharmaceuticals, diagnostic drugs production company.

orthogon-therapeutics-logo

Orthogon Therapeutics

Orthogon Therapeutics is a drug development company.

pleryon-therapeutics-logo

Pleryon Therapeutics

Pleryon Therapeutics is a drug delivery platform company.


Current Advisors List

sameer-mehta_image

Sameer Mehta Board of Director @ Avammune Therapeutics
Board_member

not_available_image

Kate Fitzgerald Scientific Advisor @ Avammune Therapeutics
Advisor

not_available_image

Jean-Franรงois Paquin Scientific Advisor @ Avammune Therapeutics
Advisor

george-church_image

George Church Scientific Advisor @ Avammune Therapeutics
Advisor

Current Employees Featured

aditya-kulkarni_image

Aditya Kulkarni
Aditya Kulkarni Founder and Chief Scientific Officer @ Avammune Therapeutics
Founder and Chief Scientific Officer
2018-03-01

arun-papaiah_image

Arun Papaiah
Arun Papaiah Co Founder and CEO @ Avammune Therapeutics
Co Founder and CEO
2018-03-01

Founder


aditya-kulkarni_image

Aditya Kulkarni

arun-papaiah_image

Arun Papaiah

Investors List

the-chennai-angels_image

The Chennai Angels

The Chennai Angels investment in Venture Round - Avammune Therapeutics

Official Site Inspections

http://www.avammune.com Semrush global rank: 15.27 M Semrush visits lastest month: 14

  • Host name: 0.238.178.68.host.secureserver.net
  • IP address: 68.178.238.0
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Avammune Therapeutics"

Avammune Therapeutics

Avammune Therapeutics is a small molecule drug discovery and development company developing modulators of the innate immune system. Avammuneโ€™s โ€ฆSee details»

Avammune Therapeutics - Crunchbase Company โ€ฆ

Avammune Therapeutics is a drug discovery company focused on immuno โ€ฆSee details»

Avammune Therapeutics - LinkedIn

Avammune Therapeutics is a drug discovery company focused on the development of novel immunotherapeutics to address high unmet medical needs. Our research is driven by the โ€ฆSee details»

Avammune Therapeutics 2025 Company Profile: Valuation, โ€ฆ

Information on valuation, funding, cap tables, investors, and executives for Avammune Therapeutics. Use the PitchBook Platform to explore the full profile.See details»

Avammune Therapeutics Company Profile - Craft

See insights on Avammune Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Avammune Therapeutics - Snapshot | One21

May 12, 2025 Avammune Therapeutics is a cutting-edge biopharmaceutical company focused on discovering and developing small molecule medicines that harness the power of the bodyโ€™s โ€ฆSee details»

Avammune Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap

May 8, 2025 100 Clinical Results associated with Avammune Therapeutics, Inc. Login to view more data 0 Patents (Medical) associated with Avammune Therapeutics, Inc. Login to view โ€ฆSee details»

Avammune Therapeutics - A Health Tech Funded Company Based โ€ฆ

Founded in 2020, Avammune Therapeutics operates in the healthtech sector, specializing in immunotherapy solutions. Initially focusing on innovative treatments for autoimmune diseases, โ€ฆSee details»

Avammune Therapeutics - VentureRadar

"Avammune Therapeutics Inc. (formerly known as Straximm Therapeutics), a spin-off from Aten Porus Lifesciences (Bangalore, India), is developing highly potent and specific small molecule โ€ฆSee details»

Avammune Therapeutics - News, Locations, Executives and โ€ฆ

Usearch has identified 2 executives & key decision-makers. The company domain name is avammune.com.See details»

Avammune Therapeutics Overview | SignalHire Company Profile

Avammune Therapeutics is a drug discovery company focused on the development of novel immunotherapeutics to address high unmet medical needs. Our research is driven by the โ€ฆSee details»

Avammune Therapeutics Raises INR 100 Crore in Series A

May 12, 2025 Avammune Therapeutics, a bengaluru-based healthtech startup, has raised INR 100 crore ($12 million) in a Series A funding round co-led by Capital 2B, Shastra VC, and โ€ฆSee details»

Indian healthtech startup Avammune nets $12m series A

May 12, 2025 Avammune Therapeutics, a India-based healthtech startup, has raised US$12 million in its series A funding round. The investment was co-led by Capital 2B, Shastra VC, โ€ฆSee details»

Avammune Therapeutics - Funding, Financials, Valuation & Investors

Avammune Therapeutics is a drug discovery company.in funding over 3 rounds. Their latest funding was raised on May 7, 2025 from a Series A round.See details»

Avammune Therapeutics Raises $12 Million in Series A Funding

May 12, 2025 Avammune Therapeutics, along with its subsidiary Avammune Lifesciences, has raised $12 million (approximately โ‚น100 crore) in a Series A round co-led by Capital 2B, โ€ฆSee details»

Avammune Secures $12M to Advance Cancer Immunotherapy

May 12, 2025 Indian startup Avammune raises $12M to scale immune-based cancer treatment and launch clinical trials using AI-driven drug discovery.See details»

Avammune Therapeutics Raises $12 Million in Series A to Advance โ€ฆ

May 11, 2025 A vammune Therapeutics, along with its subsidiary Avammune Lifesciences, has secured $12 million (approximately โ‚น100 crore) in a Series A funding round co-led by Capital โ€ฆSee details»

Avammune Therapeutics, Posha, InspeCity, others secure funding

May 7, 2025 Biopharma startup Avammune Therapeutics, robotics company Posha, space-tech firm InspeCity, logistics startup Shiplog, health-tech company Lifechart, insurance startup โ€ฆSee details»

Avammune Therapeutics - Contacts, Employees, Board Members, โ€ฆ

Avammune Therapeutics is a drug discovery company.Avammune Therapeutics has 2 current employee profiles, including Founder and Chief Scientific Officer Aditya Kulkarni. Avammune โ€ฆSee details»

Avammune Therapeutics - Updates, News, Events, Signals & Triggers

Avammune Therapeutics is a drug discovery company.Avammune Therapeutics raised $12 million in a Series A funding round co-led by Capital 2B, Shastra VC, and Kotak Lifesciences โ€ฆSee details»

linkstock.net © 2022. All rights reserved